Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis - Université de Lorraine
Journal Articles New England Journal of Medicine Year : 2019

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

Bruce Sands
  • Function : Author
William Sandborn
  • Function : Author
Remo Panaccione
  • Function : Author
Christopher O’brien
  • Function : Author
Hongyan Zhang
Jewel Johanns
  • Function : Author
Omoniyi Adedokun
  • Function : Author
Katherine Li
  • Function : Author
Laurent Peyrin-Biroulet
Centre Hospitalier Régional Universitaire de Nancy
Nutrition-Génétique et Exposition aux Risques Environnementaux
Gert van Assche
  • Function : Author
Silvio Danese
Humanitas Clinical and Research Center [Rozzano, Milan, Italy]
Stephan Targan
  • Function : Author
Maria Abreu
  • Function : Author
Tadakazu Hisamatsu
  • Function : Author
Philippe Szapary
  • Function : Author
Colleen Marano
  • Function : Author

Domains

Life Sciences [q-bio]

Djésia Arnone  : Connect in order to contact the contributor

https://hal.univ-lorraine.fr/hal-03144504

Submitted on : Wednesday, February 17, 2021-4:32:40 PM

Last modification on : Tuesday, October 10, 2023-10:22:40 AM

Consult the full text

Dates and versions

hal-03144504 , version 1 (17-02-2021)

Identifiers

Cite

Bruce Sands, William Sandborn, Remo Panaccione, Christopher O’brien, Hongyan Zhang, et al.. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. New England Journal of Medicine, 2019, 381 (13), pp.1201-1214. ⟨10.1056/NEJMoa1900750⟩. ⟨hal-03144504⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-LORRAINE NGERE-UL BMS-UL
16 View
0 Download

Altmetric

Share

More